1. Home
  2. TECX vs UIS Comparison

TECX vs UIS Comparison

Compare TECX & UIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECX
  • UIS
  • Stock Information
  • Founded
  • TECX 2019
  • UIS 1942
  • Country
  • TECX United States
  • UIS United States
  • Employees
  • TECX N/A
  • UIS N/A
  • Industry
  • TECX
  • UIS EDP Services
  • Sector
  • TECX
  • UIS Technology
  • Exchange
  • TECX Nasdaq
  • UIS Nasdaq
  • Market Cap
  • TECX 334.4M
  • UIS 271.5M
  • IPO Year
  • TECX 2018
  • UIS N/A
  • Fundamental
  • Price
  • TECX $19.81
  • UIS $4.14
  • Analyst Decision
  • TECX Buy
  • UIS Hold
  • Analyst Count
  • TECX 7
  • UIS 1
  • Target Price
  • TECX $78.67
  • UIS $6.50
  • AVG Volume (30 Days)
  • TECX 156.7K
  • UIS 612.4K
  • Earning Date
  • TECX 08-13-2025
  • UIS 08-04-2025
  • Dividend Yield
  • TECX N/A
  • UIS N/A
  • EPS Growth
  • TECX N/A
  • UIS N/A
  • EPS
  • TECX N/A
  • UIS N/A
  • Revenue
  • TECX N/A
  • UIS $1,952,700,000.00
  • Revenue This Year
  • TECX N/A
  • UIS N/A
  • Revenue Next Year
  • TECX N/A
  • UIS $3.79
  • P/E Ratio
  • TECX N/A
  • UIS N/A
  • Revenue Growth
  • TECX N/A
  • UIS N/A
  • 52 Week Low
  • TECX $13.70
  • UIS $3.32
  • 52 Week High
  • TECX $61.07
  • UIS $8.93
  • Technical
  • Relative Strength Index (RSI)
  • TECX 40.56
  • UIS 41.35
  • Support Level
  • TECX $22.13
  • UIS $4.41
  • Resistance Level
  • TECX $25.75
  • UIS $5.08
  • Average True Range (ATR)
  • TECX 1.44
  • UIS 0.19
  • MACD
  • TECX -0.48
  • UIS -0.06
  • Stochastic Oscillator
  • TECX 10.68
  • UIS 8.98

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About UIS Unisys Corporation New

Unisys Corp is engaged in the provision of technology solutions for clients across the government, financial services, and commercial markets. It operates through three business segments: Digital Workplace Solutions (DWS),Cloud, Applications & Infrastructure Solutions (CA&I), and Enterprise Computing Solutions (ECS). DWS provides workplace solutions featuring intelligent workplace services, proactive experience management and collaboration tools to support business growth. CA&I which provides digital transformation in the areas of cloud migration and management. ECS which provides solutions that harness secure, high-intensity enterprise computing and enable digital services through software-defined operating environments. Majority of revenue is from ECS segment.

Share on Social Networks: